Skip to primary navigation
Skip to main content
Skip to footer

Home

About Us
Newsroom
Partnering
Investors
Contact Us

SITC: CYAD-101: an allogeneic NKG2D CAR T cell therapy using a TCR inhibitory molecule

November 18, 2018

Footer

Celyad Oncology

About
Newsroom
Partnering
Investors
Contact Us

Copyright © 2026 All Rights Reserved.

Cookie Policy |
Privacy Policy |
Terms of Use